The Spectrum of Phenylalanine Variations Under Tetrahydrobiopterin Load in Subjects Affected by Phenylalanine Hydroxylase Deficiency

Overview

Journal J Inherit Metab Dis

Publisher Wiley

Date 2006 Apr 8

PMID 16601866

Citations 18

Authors

V Leuzzi

C Carducci

F Chiarotti

C Artiola

T Giovanniello

I Antonozzi

Affiliations

Soon will be listed here.

Abstract

A fall in blood phenylalanine (Phe) after tetrahydrobiopterin (BH(4)) administration is a common trait in phenylalanine hydroxylase (PAH, EC 1.14.16.1) deficiency (McKusick 261600). To explore the extent and biological correlates of this phenomenon we studied: (a) the spectrum of BH(4) response in patients with PAH deficiency; (b) the variability of BH(4) response according to the severity of the biochemical phenotype; and (c) the variability of the response to BH(4) in subjects with the same genotype. Fifty PAH-deficient subjects (age 1 month-35 years) were enrolled for the study (5 with mild hyperphenylalaninaemia (MHPHE), 15 with mild phenylketonuria (MPKU) and 30 with classic phenylketonuria (CPKU) and underwent an identical schedule of blood samplings 24 h before and after oral BH(4) challenge (6(R)-BH4, 20 mg/kg per day), leaving Phe intake unchanged. The effect of BH(4) on blood Phe concentration was evaluated according to the percent decrease of Phe during the 24 h following the challenge (criterion a), and as variation exceeding the individual variability of blood Phe (criterion b). The number of BH(4)-responders according to criterion b was 31 (including all the 14 detected by criterion a): 17 out of 30 CPKU (57%), 9 out of 15 MPKU (60%), and all the MHPHE subjects (chi(2) = 3.45, df = 2, p = 0.178). The effect of BH(4) showed a large interindividual variability unrelated to diagnostic classification, basal value of blood Phe, maximum percentage of Phe reduction, Phe intake, and genotype. Some inconsistencies were found in patients with identical genotype. The first responsive case homozygous for the severe R408W mutation was found. Two new mutations, Y387X and G352C, were identified (the former was BH(4)-responsive), and the responsiveness of three already reported mutations (R261Q, D338Y, T92I) was substantiated.

Citing Articles

Maximal dietary responsiveness after tetrahydrobiopterin (BH4) in 19 phenylalanine hydroxylase deficiency patients: What super-responders can expect.

Upadia J, Crivelly K, Noh G, Cunningham A, Cerminaro C, Li Y Mol Genet Metab Rep. 2024; 38:101050.

PMID: 38469087 PMC: 10926188. DOI: 10.1016/j.ymgmr.2024.101050.

Italian national consensus statement on management and pharmacological treatment of phenylketonuria.

Burlina A, Biasucci G, Carbone M, Cazzorla C, Paci S, Pochiero F Orphanet J Rare Dis. 2021; 16(1):476.

PMID: 34784942 PMC: 8594187. DOI: 10.1186/s13023-021-02086-8.

Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels.

Romani C, Manti F, Nardecchia F, Valentini F, Fallarino N, Carducci C Orphanet J Rare Dis. 2019; 14(1):273.

PMID: 31779649 PMC: 6883518. DOI: 10.1186/s13023-019-1225-z.

The Predictive Value of Genetic Analyses in the Diagnosis of Tetrahydrobiopterin (BH4)-Responsiveness in Chinese Phenylalanine Hydroxylase Deficiency Patients.

Zhu T, Ye J, Han L, Qiu W, Zhang H, Liang L Sci Rep. 2017; 7(1):6762.

PMID: 28754886 PMC: 5533732. DOI: 10.1038/s41598-017-06462-y.

Phenylketonuria: translating research into novel therapies.

Ho G, Christodoulou J Transl Pediatr. 2016; 3(2):49-62.

PMID: 26835324 PMC: 4729111. DOI: 10.3978/j.issn.2224-4336.2014.01.01.

References

Koch R, Guttler F, Blau N . Mental illness in mild PKU responds to biopterin. Mol Genet Metab. 2002; 75(3):284-6. DOI: 10.1006/mgme.2001.3289. View

Matalon R, Koch R, Michals-Matalon K, Moseley K, Surendran S, Tyring S . Biopterin responsive phenylalanine hydroxylase deficiency. Genet Med. 2004; 6(1):27-32. DOI: 10.1097/01.gim.0000108840.17922.a7. View

Desviat L, Perez B, Belanger-Quintana A, Castro M, Aguado C, Sanchez A . Tetrahydrobiopterin responsiveness: results of the BH4 loading test in 31 Spanish PKU patients and correlation with their genotype. Mol Genet Metab. 2004; 83(1-2):157-62. DOI: 10.1016/j.ymgme.2004.06.007. View

Kure S, Hou D, Ohura T, Iwamoto H, Suzuki S, Sugiyama N . Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J Pediatr. 1999; 135(3):375-8. DOI: 10.1016/s0022-3476(99)70138-1. View

Erlandsen H, Stevens R . A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria. J Inherit Metab Dis. 2001; 24(2):213-30. DOI: 10.1023/a:1010371002631. View

Blau N, Erlandsen H . The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Mol Genet Metab. 2004; 82(2):101-11. DOI: 10.1016/j.ymgme.2004.03.006. View

Lassker U, Zschocke J, Blau N, Santer R . Tetrahydrobiopterin responsiveness in phenylketonuria. Two new cases and a review of molecular genetic findings. J Inherit Metab Dis. 2002; 25(1):65-70. DOI: 10.1023/a:1015194002487. View

Spaapen L, Bakker J, Velter C, Loots W, Rubio-Gozalbo M, Forget P . Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Dutch neonates. J Inherit Metab Dis. 2001; 24(3):352-8. DOI: 10.1023/a:1010596317296. View

Antonozzi I, Carducci C, Vestri L, Pontecorvi A, Moretti F . Rapid and sensitive method for high-performance liquid chromatographic analysis of pterins in biological fluids. J Chromatogr. 1988; 459:319-24. DOI: 10.1016/s0021-9673(01)82042-2. View

10.

Chehin R, Thorolfsson M, Knappskog P, Martinez A, Flatmark T, Arrondo J . Domain structure and stability of human phenylalanine hydroxylase inferred from infrared spectroscopy. FEBS Lett. 1998; 422(2):225-30. DOI: 10.1016/s0014-5793(97)01596-2. View

11.

Muntau A, Roschinger W, Habich M, Demmelmair H, Hoffmann B, Sommerhoff C . Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med. 2002; 347(26):2122-32. DOI: 10.1056/NEJMoa021654. View

12.

Blau N, Trefz F . Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency: possible regulation of gene expression in a patient with the homozygous L48S mutation. Mol Genet Metab. 2002; 75(2):186-7. DOI: 10.1006/mgme.2001.3294. View

13.

Moretti F, Birarelli M, Carducci C, Pontecorvi A, Antonozzi I . Simultaneous high-performance liquid chromatographic determination of amino acids in a dried blood spot as a neonatal screening test. J Chromatogr. 1990; 511:131-6. DOI: 10.1016/s0021-9673(01)93278-9. View

14.

Steinfeld R, Kohlschutter A, Ullrich K, Lukacs Z . A hypothesis on the biochemical mechanism of BH(4)-responsiveness in phenylalanine hydroxylase deficiency. Amino Acids. 2003; 25(1):63-8. DOI: 10.1007/s00726-002-0354-0. View

15.

Fiege B, Ballhausen D, Kierat L, Leimbacher W, Goriounov D, Schircks B . Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration. Mol Genet Metab. 2004; 81(1):45-51. DOI: 10.1016/j.ymgme.2003.09.014. View

16.

Bardelli T, Donati M, Gasperini S, Ciani F, Belli F, Blau N . Two novel genetic lesions and a common BH4-responsive mutation of the PAH gene in Italian patients with hyperphenylalaninemia. Mol Genet Metab. 2002; 77(3):260-6. DOI: 10.1016/s1096-7192(02)00166-x. View

17.

Guldberg P, Romano V, Ceratto N, Bosco P, Ciuna M, Indelicato A . Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: implications for diagnosis of hyperphenylalaninemia in southern Europe. Hum Mol Genet. 1993; 2(10):1703-7. DOI: 10.1093/hmg/2.10.1703. View

18.

Lindner M, Steinfeld R, Burgard P, Schulze A, Mayatepek E, Zschocke J . Tetrahydrobiopterin sensitivity in German patients with mild phenylalanine hydroxylase deficiency. Hum Mutat. 2003; 21(4):400. DOI: 10.1002/humu.9117. View

19.

Trefz F, Blau N . Successful treatment of phenylketonuria with tetrahydrobiopterin. Eur J Pediatr. 2001; 160(5):315. DOI: 10.1007/pl00008436. View

20.

Erlandsen H, Pey A, Gamez A, Perez B, Desviat L, Aguado C . Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations. Proc Natl Acad Sci U S A. 2004; 101(48):16903-8. PMC: 534739. DOI: 10.1073/pnas.0407256101. View